Metabolic disorders can activate renin-angiotensin-aldosterone system (RAAS), increase angiotensin II and aldosterone activity, which leads to cardiomyocyte hypertrophy, increased cardiac fibroblast proliferation and myocardial remodeling acceleration (32, 34). Here, AGT is linked to Other metabolic disease.